Beyond conflict of interest (1999)

# What is truth as it relates to albumin? {#article-title-2} EDITOR—The editor of the BMJ is so busy pointing the finger at others' conflicts of interest1 that he ignores one lurking at his own front door. I refer to the continuing controversy over albumin. Editors have to sell their journal, although giving a copy free to every member of the BMA does create a captive market that other editors do not enjoy. The conflict here is the editor's need to feature in the media competing with readers' need to be told the truth. What is truth and what is tendentious opinion masquerading as gospel? Offringa tried to clarify his original message2 when he said that by writing “halted” he meant that the use of albumin should not be halted.3 Is he to be criticised for over-egging the pudding, or is the editor to be criticised more for producing a mouse and calling it a mountain? 1. ↵1. Smith R .Beyond conflict of interest.BMJ1998; 317: 291–292. (1 August.) [OpenUrl][1][FREE Full Text][2] 2. ↵1. Offringa M .Excess mortality after human albumin administration in critically ill patients.BMJ1998; 317: 223–224. (25 July.) [OpenUrl][3][FREE Full Text][4] 3. ↵1. Offringa M .Consider validity, clinical relevance, and applicability of albumin for critically ill patients.BMJ1998; 317: 343. (1 August.) [OpenUrl][5][FREE Full Text][6] # BMJ's editors should publish their own conflicts of interest regularly {#article-title-6} EDITOR—The BMJ has now joined several prominent medical journals that have clarified or revised their conflict of interest policies.1 I hope that it fares better than its counterparts in evenhandedly enforcing its revised policy. In one well publicised case, a single day's consulting to a panel of the Food and Drugs Administration was considered such a profound violation that the New England Journal of Medicine changed its rules about conflict of interest.2 In the case of an editorial in that jounal which flatly dismissed the carcinogenic potential of environmental oestrogens, however, long term funding from the chemical industry to the author of the editorial went undisclosed, and when disclosed was addressed by the editor's comment that “the line has to be drawn somewhere.”3 The executive editor of the New England Journal of Medicine has also written an editorial in the Wall Street Journal suggesting that receiving grants from the … [1]: {openurl}?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DSmith%26rft.auinit1%253DR.%26rft.volume%253D317%26rft.issue%253D7154%26rft.spage%253D291%26rft.epage%253D292%26rft.atitle%253DBeyond%2Bconflict%2Bof%2Binterest%26rft_id%253Dinfo%253Apmid%252F9685268%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/ijlink?linkType=FULL&journalCode=bmj&resid=317/7154/291&atom=%2Fbmj%2F318%2F7181%2F464.2.atom [3]: {openurl}?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DOffringa%26rft.auinit1%253DM.%26rft.volume%253D317%26rft.issue%253D7153%26rft.spage%253D223%26rft.epage%253D224%26rft.atitle%253DExcess%2Bmortality%2Bafter%2Bhuman%2Balbumin%2Badministration%2Bin%2Bcritically%2Bill%2Bpatients%26rft_id%253Dinfo%253Apmid%252F9677204%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [4]: /lookup/ijlink?linkType=FULL&journalCode=bmj&resid=317/7153/223&atom=%2Fbmj%2F318%2F7181%2F464.2.atom [5]: {openurl}?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.issn%253D0007-1447%26rft.aulast%253DOffringa%26rft.auinit1%253DM.%26rft.volume%253D317%26rft.issue%253D7154%26rft.spage%253D343%26rft.epage%253D343%26rft.atitle%253DConsider%2Bvalidity%252C%2Bclinical%2Brelevance%252C%2Band%2Bapplicability%2Bof%2Balbumin%2Bfor%2Bcritically%2Bill%2Bpatients%26rft_id%253Dinfo%253Apmid%252F9685288%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [6]: /lookup/ijlink?linkType=FULL&journalCode=bmj&resid=317/7154/343&atom=%2Fbmj%2F318%2F7181%2F464.2.atom